All lobbying filings

ORCHARD THERAPEUTICS NORTH AMERICA

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Health

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $260,000.00 expenses · posted Jan 20, 2026

Official filing document

Bills named in this filing 2

HR 1262
Mikaela Naylon Give Kids a Chance Act
HR 1509
Accelerating Kids’ Access to Care Act of 2025

Lobbying activity 2

Health Issues

HR 1262/ S 932 - Give Kids a Chance Act of 2025 HR 1509/ S 752 - Accelerating Kids' Access to Care Act & Give Kids a Chance Act 2025 Newborn Screening, including Appropriations

Medicare/Medicaid

Medicaid Value-Based Payments for Patients (MVP) Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.